{"ticker": {"uuid": "a0e40646-b110-4844-93ba-cacde122db69", "symbol": "001060", "name": "JW Pharmaceutical Corporation", "exchange": "KSC", "country": "KR", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "JW Pharmaceutical leads South Korea AI-robot drive to speed cancer drug discovery - CHOSUNBIZ", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOWG5lZUpabExOUTRPVzZuOThCeWo5Wm1XRVphWHg5YTVuaHZwZ0VCTEhVaExrOXF6Nlo3TEpQdnVfUkN6aTVIRGJlTld3eUZqbFN5d0tiLVNwU2RxalRHX2hCUmRDQ1FIRGZDZzFEVzhkZ1prTVNiTDliZkxNQkh2YtIBlAFBVV95cUxNNkdTdTRlQ3JFVnJnQk9OTUZUVmhLbGZSeHpzWnFvc0JEMmpiWC11RS1pT1U2c1lGUFlmdTNMSEdOTEdZVVZHQmw5Vy1kQmNJWUx4ZXBuUFJ2T3BDYjlQNjk0b3h5cEJDMEJCOUgzSm4zcW1RZDZtcHBlUlJFVEw0ZzV1Mk9LUFF1NVBwdGlfRzF4ZXRF?oc=5", "source_name": "Chosunbiz", "published_at": "2026-06-17T00:52:00+00:00", "published_display": "17 Jun 2026 00:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hair Loss Insurance Hopes Send JW Pharmaceutical, TS Trillion to Daily Limit", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOeTVFeFRBWjNzMWtrYUhHVDlhTjJVYlh5OVlkVmtRU2lmX1Q1bUFzNGxRbVhoXzA0MHp3MDQxdGtRdm5TUjFnb2MxX3dpR3pGd2ZkTkRTTmtIZThueTgyNGkxTjNlRGJ2S3dhVU5VSGEzV3lFTkJJajFzM01CYzdiMFhyY041OEFCZUNYSnhUSUJuRDFUclhMUg?oc=5", "source_name": "Seoul Economic Daily", "published_at": "2026-06-15T02:13:20+00:00", "published_display": "15 Jun 2026 02:13", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "JW Pharmaceutical Presents Preclinical Results and Global Development Strategy for DDC-02, a Novel Therapeutic Candidate for Rare Neurodevelopmental Disorders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugJBVV95cUxQT0hPajFvbjFKaFlPeWdOVVN6TjhSQTFZaUJ2eDVvcGVRbktRSGotNFh1UnlPOXgzX2dLTm5YQnBwUzd1ZURvRzdnU3dpWW1MWVVPaEZjWGFCTHhFNkZfQ0dNdTZ4S2hqWUV2Y2IyMzNkLUZWRUhFVlFQQjlveEVnNTYzRXo2b3UxUktPeUFmczR3QVVDTkZxWkVSa2NXWVRxRExFMGljSkNoYU5EZVplZG9TMkowNTZtUy1xRXpKMThlZDIyVFBPSlI1Z1VSOG96cjRhTVd6eHB1WFJwT093dDd6dmlGemg0U3ZsWEhITXNfOTVTNWFWczRRbkVaZzdkSlBveDlacTZsU05PRnExd254VVNCWEgyeUZxTm5JVWptOUlyU0gzdHRaRnQ4THBHVXJIU3lGZ1VMQQ?oc=5", "source_name": "Business Wire", "published_at": "2026-06-11T13:00:00+00:00", "published_display": "11 Jun 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "JW Pharmaceutical finishes phase 3 dosing for epaminurad, data due this year", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE1RQlpVa2xxV01MSmxjaTM2bGItdVh2NDVPeHRFWFFxMGdEUnU0ZG1lTDgydWJfcFZLTlZ0S2xrUGc5ZXVuM0pCV0hvZURJbWpON3k2OTh3UHQ1RVQ0ZkNsTXFpdXJCR1ZQeUdHdHR30gFyQVVfeXFMTV9GOUVsWFBPMUl0VFRJQVduZDZ6UHVTdURyU21sM0twOGkyWk9IOFUzbEtpZmhCVmUwa0tJdi1MWm9IblFvdWxvd1puNmVKWlVFaGxYMmNOMEZ6SUFaWEdxQTNyZ3N0cUp4MTBSbEhPbGxR?oc=5", "source_name": "koreabiomed.com", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gan & Lee and JW Pharmaceutical agree on bofanglutide commercialisation", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOUkVwRno3RjdkSUU4SFMwWTRqNGxqU0RydVk2T3FjajlmSXJ4THN0b01uYXlUbk1NREhxeXdtVkhfcS1yamt3UWxtOHV2eVItMFNwbVRKYjhET1VRdHZ5eXl3VW45T2xRXzBXZHVLajFuN1ZuS1hTUmtMdzdGQ0RmUnBDa2Z1Uzh6U0FyaEoxamNDb0NEVVVOLW16OWNzemtiRHFaSVpTZw?oc=5", "source_name": "Pharmaceutical Technology", "published_at": "2026-04-10T07:00:00+00:00", "published_display": "10 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gan & Lee Pharmaceuticals Signs Exclusive License Agreement with JW Pharmaceutical, the Leading South Korean Pharma, to Advance the Global Commercialization of the Innovative GLP-1 Receptor Agonist Bofanglutide", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-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?oc=5", "source_name": "PR Newswire", "published_at": "2026-04-09T07:00:00+00:00", "published_display": "09 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "JW Pharmaceutical Stock Rises on Exclusive Obesity Drug Licensing Deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNbXQzNFN6V0JENGZKaHFFQXFzcHNld3plZGJfbFRLLWdWNDd4TzRaU091YWFJVXUtLUFrRXZKOXpwOGpfaHhpVl9TT1RlTVROSVpWUzR6ZGJoVU8yS0psYmc3ekIxZGxqWDhvNDh4M25nU2I2YUVYQ2tkOTZQTzlnVzN3UjYwWkV5b21RY0ktdVBXUEZqM1gtMzh5R2d1dw?oc=5", "source_name": "Seoul Economic Daily", "published_at": "2026-04-09T07:00:00+00:00", "published_display": "09 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "JW Pharmaceutical secures GLP-1 drug rights in $81m deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTFBiOTBwanJOaXdySTUzdUZGeEsxN0FaSkFKN3hENWFBWWhXUXNuNWI5b29wXzZYeURnYTVNZHpPTWVPR2p0eWdMaGxqTFdaUXk4SGlubmk0OA?oc=5", "source_name": "The Korea Herald", "published_at": "2026-04-09T07:00:00+00:00", "published_display": "09 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "JW Pharmaceutical signs $81 mil. license-in deal with China's Gan & Lee for GLP-1 obesity drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE9CNnlDaU5Od2FPUGVMcndEdERTVjB5SS01Y1BpME9xT2l0d2xPVjdkajNSMDMwSXNjdGVnbVhRU25LRXRNRmZrbWUyWUNQaV9WZ0JOUzc5Q0hMMnV4UXhTU0hHSXQtSXN0LU80enN30gFyQVVfeXFMTVZRTW1HUjZJeGxTZTR0Uk5ta2pid0FlOFpUemowS3dfSEpkRHA4V1hJbnBFR1dnWEtxRGJNNjV5WlBPOW0wYkg0M1NsYmtmQXdGT3gyTWdLRVF4eHpNSVlwN2FPY0xVR2xRZGpNVE11S1NR?oc=5", "source_name": "koreabiomed.com", "published_at": "2026-04-09T07:00:00+00:00", "published_display": "09 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "JW Pharmaceutical advances fourth-generation leadership as Korea hair loss drug enters trials - CHOSUNBIZ", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxNVE5rU09MOElYTk1XNlBqYlAtU3I4ZmltNEZ0RXNjS0ZSZzB5VGk5M3RlTDZwTlltM2E5ZTVFeGplYkIwWGpGWThLZ0ZkNTJSYWNxTUlobXhZWVhPUF9Mb3VyV0h3em96OFJLQ29DZkZ5RnpNSDQ3MVMzcDM2QWUxatIBlAFBVV95cUxOaDJNTEF5WmNRT2dDNkd3RjZyTGsxN1dudWs2d05UbFlZYTFCWWF2azc4VXZtWHgwX3A1bVhKRnFzZ0IwWmpTTTN5LW5sSGI5dDAxVGtFMTFLQ3d6WmxRVWRPRkFiUlBJc0VjZ2VSZ0UydnJuc3VYVEFYWXNUVXJRU3pFZmMtRjlwUTU3SExiSFAtYUNn?oc=5", "source_name": "Chosunbiz", "published_at": "2026-03-27T07:00:00+00:00", "published_display": "27 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "JW Pharmaceutical OKed for phase 1 novel hair loss drug trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTFBVRHRjY04tb0ZtVVdSenRrNkRPU3BTWHdIdFZobmRBQlVTU1FkdnpvQ3RZZE85MExrU1JNVklzREt4d3NvSTBvV1VJSDluUFVOY3pScVpzbU00TVFRRGlSYUhRaFBtR3haZTR2NFpB0gFyQVVfeXFMTkg1TjlJampUU1NnaFVQWTRtd1E2X094SlJ3MmVxelFqckpETmtVS01RMHE3Zko2YWpVVnpIR3Q1anVURGdlTlZCUjRQem11UWVPelZSQzdjUlRRZzhyZjEzcV83YlFXYXFZQ3BIVFdDSWV3?oc=5", "source_name": "koreabiomed.com", "published_at": "2026-02-13T08:00:00+00:00", "published_display": "13 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "JW Pharmaceutical shares real-world prescribing data for immune thrombocytopenia drug Tavalisse", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE1Hd0RWQlZZWktHMXdXa0diUG9mQ1dPc3JnMUFPVFZKNUItY0c5QVBkWnF3MUpWSmVPMk5vUDRXajFUMVlMR2tRS0hDNk1uUGExSGNPSzlkZ1htVlRna2VFZFR0MmRSSmh4RU9qUDlB0gFyQVVfeXFMTzJLMWNjSHVTWU9qbUdIOUE4dk83QmRJSGRBSjhQZndDTVhQZk5yQUdsZGRJdHlseG5iM3Nubm5NSGJ5LVpZQi0xeWd3aGRmR3Z6ZjQxZVBqUTRYWDhscF8zSTFwRWJGT2FOdGJDOUdRSk9n?oc=5", "source_name": "koreabiomed.com", "published_at": "2026-01-26T08:00:00+00:00", "published_display": "26 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "JW Pharmaceutical Registers U.S. Patent for Hair Loss Treatment JW0061", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxQYjRQbzhDX0wtZml5RkU0SEE3SkpZd2Y0VzdvZXJELXBOakE1cmlmM21GS3djeHFlRGhtVG9BdmlNSU1hN2w3YXNaaV9Wc3NMNGtZYmpST0hqQmJUaVhUSS1FejlwcG04RDNzSGdETVlSbkJYUHpLSl92WU5tellFWVRKcm4tZUpQ?oc=5", "source_name": "\uc870\uc120\uc77c\ubcf4", "published_at": "2026-01-19T08:00:00+00:00", "published_display": "19 Jan 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "JW Pharmaceutical\u2019s Hemlibra earns spot on WHO\u2019s 2025 essential medicines list for hemophilia A", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTFA2QVZQNXdlcjBuWnlTVzJXTjNGd25xbUxyNjZSdGVXUzF6XzlsWDBsWVhkSWRfOVJxR0ZCUk5sRFlOenZBSTZ3TEtBR1hrSHEyTlpZdV9yUE9PdmFxQjUwYjRUUlFzYTJPQXQ0TWJ30gFyQVVfeXFMTlEtckJFd2ZpTkowR1FBdnd0aEZZMDlsV192OTV6VnhXZnpHTDNWV1R3NXRpU2FuU2xtYmdBb0FCT0U5MlQ0OUlhR2ItU2ZxMkxQbFhyZjNsQnVBVGJZdEt3ODUyeWYzVHZZbm0xNmtOZEd3?oc=5", "source_name": "koreabiomed.com", "published_at": "2025-10-20T07:00:00+00:00", "published_display": "20 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LEO Pharma returns rights for atopic dermatitis drug candidate to JW Pharmaceutical due to lack of efficacy", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE5JYWJiVW51bDItQlpKQzhGcFZxZl9ZbDNTcE54eDQ1NTd1UnVkMTlCdVRvdkxjc2FmclhseVdKcWZUMXp2el9ieUNGY19BelU2dko1NzZwRzJ1TnJHYmhRdWMwbXUxYWNkelhlcXhR0gFyQVVfeXFMTjJNNG9rR01rZ2I0MEhxN2tJQnFLZHhmNGljV3Z3QnlUUTdyUEVZSU9NMzJ0emVZLTIyaDF2ZTgxWk5rY19YNExtWXh6a2lyX0c4a0FBbnI1eDVXVkxBZnZCay1iTXhDNm5Xd3Z2WHhTS3VR?oc=5", "source_name": "koreabiomed.com", "published_at": "2023-10-23T07:00:00+00:00", "published_display": "23 Oct 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "JW Pharmaceutical leads South Korea AI-robot drive to speed cancer drug discovery - CHOSUNBIZ", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOWG5lZUpabExOUTRPVzZuOThCeWo5Wm1XRVphWHg5YTVuaHZwZ0VCTEhVaExrOXF6Nlo3TEpQdnVfUkN6aTVIRGJlTld3eUZqbFN5d0tiLVNwU2RxalRHX2hCUmRDQ1FIRGZDZzFEVzhkZ1prTVNiTDliZkxNQkh2YtIBlAFBVV95cUxNNkdTdTRlQ3JFVnJnQk9OTUZUVmhLbGZSeHpzWnFvc0JEMmpiWC11RS1pT1U2c1lGUFlmdTNMSEdOTEdZVVZHQmw5Vy1kQmNJWUx4ZXBuUFJ2T3BDYjlQNjk0b3h5cEJDMEJCOUgzSm4zcW1RZDZtcHBlUlJFVEw0ZzV1Mk9LUFF1NVBwdGlfRzF4ZXRF?oc=5", "source_name": "Chosunbiz", "published_at": "2026-06-17T00:52:00+00:00", "published_display": "17 Jun 2026 00:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hair Loss Insurance Hopes Send JW Pharmaceutical, TS Trillion to Daily Limit", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOeTVFeFRBWjNzMWtrYUhHVDlhTjJVYlh5OVlkVmtRU2lmX1Q1bUFzNGxRbVhoXzA0MHp3MDQxdGtRdm5TUjFnb2MxX3dpR3pGd2ZkTkRTTmtIZThueTgyNGkxTjNlRGJ2S3dhVU5VSGEzV3lFTkJJajFzM01CYzdiMFhyY041OEFCZUNYSnhUSUJuRDFUclhMUg?oc=5", "source_name": "Seoul Economic Daily", "published_at": "2026-06-15T02:13:20+00:00", "published_display": "15 Jun 2026 02:13", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "JW Pharmaceutical Presents Preclinical Results and Global Development Strategy for DDC-02, a Novel Therapeutic Candidate for Rare Neurodevelopmental Disorders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugJBVV95cUxQT0hPajFvbjFKaFlPeWdOVVN6TjhSQTFZaUJ2eDVvcGVRbktRSGotNFh1UnlPOXgzX2dLTm5YQnBwUzd1ZURvRzdnU3dpWW1MWVVPaEZjWGFCTHhFNkZfQ0dNdTZ4S2hqWUV2Y2IyMzNkLUZWRUhFVlFQQjlveEVnNTYzRXo2b3UxUktPeUFmczR3QVVDTkZxWkVSa2NXWVRxRExFMGljSkNoYU5EZVplZG9TMkowNTZtUy1xRXpKMThlZDIyVFBPSlI1Z1VSOG96cjRhTVd6eHB1WFJwT093dDd6dmlGemg0U3ZsWEhITXNfOTVTNWFWczRRbkVaZzdkSlBveDlacTZsU05PRnExd254VVNCWEgyeUZxTm5JVWptOUlyU0gzdHRaRnQ4THBHVXJIU3lGZ1VMQQ?oc=5", "source_name": "Business Wire", "published_at": "2026-06-11T13:00:00+00:00", "published_display": "11 Jun 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "JW Pharmaceutical finishes phase 3 dosing for epaminurad, data due this year", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE1RQlpVa2xxV01MSmxjaTM2bGItdVh2NDVPeHRFWFFxMGdEUnU0ZG1lTDgydWJfcFZLTlZ0S2xrUGc5ZXVuM0pCV0hvZURJbWpON3k2OTh3UHQ1RVQ0ZkNsTXFpdXJCR1ZQeUdHdHR30gFyQVVfeXFMTV9GOUVsWFBPMUl0VFRJQVduZDZ6UHVTdURyU21sM0twOGkyWk9IOFUzbEtpZmhCVmUwa0tJdi1MWm9IblFvdWxvd1puNmVKWlVFaGxYMmNOMEZ6SUFaWEdxQTNyZ3N0cUp4MTBSbEhPbGxR?oc=5", "source_name": "koreabiomed.com", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gan & Lee and JW Pharmaceutical agree on bofanglutide commercialisation", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOUkVwRno3RjdkSUU4SFMwWTRqNGxqU0RydVk2T3FjajlmSXJ4THN0b01uYXlUbk1NREhxeXdtVkhfcS1yamt3UWxtOHV2eVItMFNwbVRKYjhET1VRdHZ5eXl3VW45T2xRXzBXZHVLajFuN1ZuS1hTUmtMdzdGQ0RmUnBDa2Z1Uzh6U0FyaEoxamNDb0NEVVVOLW16OWNzemtiRHFaSVpTZw?oc=5", "source_name": "Pharmaceutical Technology", "published_at": "2026-04-10T07:00:00+00:00", "published_display": "10 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gan & Lee Pharmaceuticals Signs Exclusive License Agreement with JW Pharmaceutical, the Leading South Korean Pharma, to Advance the Global Commercialization of the Innovative GLP-1 Receptor Agonist Bofanglutide", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-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?oc=5", "source_name": "PR Newswire", "published_at": "2026-04-09T07:00:00+00:00", "published_display": "09 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "JW Pharmaceutical Stock Rises on Exclusive Obesity Drug Licensing Deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNbXQzNFN6V0JENGZKaHFFQXFzcHNld3plZGJfbFRLLWdWNDd4TzRaU091YWFJVXUtLUFrRXZKOXpwOGpfaHhpVl9TT1RlTVROSVpWUzR6ZGJoVU8yS0psYmc3ekIxZGxqWDhvNDh4M25nU2I2YUVYQ2tkOTZQTzlnVzN3UjYwWkV5b21RY0ktdVBXUEZqM1gtMzh5R2d1dw?oc=5", "source_name": "Seoul Economic Daily", "published_at": "2026-04-09T07:00:00+00:00", "published_display": "09 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "JW Pharmaceutical secures GLP-1 drug rights in $81m deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTFBiOTBwanJOaXdySTUzdUZGeEsxN0FaSkFKN3hENWFBWWhXUXNuNWI5b29wXzZYeURnYTVNZHpPTWVPR2p0eWdMaGxqTFdaUXk4SGlubmk0OA?oc=5", "source_name": "The Korea Herald", "published_at": "2026-04-09T07:00:00+00:00", "published_display": "09 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "JW Pharmaceutical signs $81 mil. license-in deal with China's Gan & Lee for GLP-1 obesity drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE9CNnlDaU5Od2FPUGVMcndEdERTVjB5SS01Y1BpME9xT2l0d2xPVjdkajNSMDMwSXNjdGVnbVhRU25LRXRNRmZrbWUyWUNQaV9WZ0JOUzc5Q0hMMnV4UXhTU0hHSXQtSXN0LU80enN30gFyQVVfeXFMTVZRTW1HUjZJeGxTZTR0Uk5ta2pid0FlOFpUemowS3dfSEpkRHA4V1hJbnBFR1dnWEtxRGJNNjV5WlBPOW0wYkg0M1NsYmtmQXdGT3gyTWdLRVF4eHpNSVlwN2FPY0xVR2xRZGpNVE11S1NR?oc=5", "source_name": "koreabiomed.com", "published_at": "2026-04-09T07:00:00+00:00", "published_display": "09 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "JW Pharmaceutical advances fourth-generation leadership as Korea hair loss drug enters trials - CHOSUNBIZ", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxNVE5rU09MOElYTk1XNlBqYlAtU3I4ZmltNEZ0RXNjS0ZSZzB5VGk5M3RlTDZwTlltM2E5ZTVFeGplYkIwWGpGWThLZ0ZkNTJSYWNxTUlobXhZWVhPUF9Mb3VyV0h3em96OFJLQ29DZkZ5RnpNSDQ3MVMzcDM2QWUxatIBlAFBVV95cUxOaDJNTEF5WmNRT2dDNkd3RjZyTGsxN1dudWs2d05UbFlZYTFCWWF2azc4VXZtWHgwX3A1bVhKRnFzZ0IwWmpTTTN5LW5sSGI5dDAxVGtFMTFLQ3d6WmxRVWRPRkFiUlBJc0VjZ2VSZ0UydnJuc3VYVEFYWXNUVXJRU3pFZmMtRjlwUTU3SExiSFAtYUNn?oc=5", "source_name": "Chosunbiz", "published_at": "2026-03-27T07:00:00+00:00", "published_display": "27 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "JW Pharmaceutical OKed for phase 1 novel hair loss drug trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTFBVRHRjY04tb0ZtVVdSenRrNkRPU3BTWHdIdFZobmRBQlVTU1FkdnpvQ3RZZE85MExrU1JNVklzREt4d3NvSTBvV1VJSDluUFVOY3pScVpzbU00TVFRRGlSYUhRaFBtR3haZTR2NFpB0gFyQVVfeXFMTkg1TjlJampUU1NnaFVQWTRtd1E2X094SlJ3MmVxelFqckpETmtVS01RMHE3Zko2YWpVVnpIR3Q1anVURGdlTlZCUjRQem11UWVPelZSQzdjUlRRZzhyZjEzcV83YlFXYXFZQ3BIVFdDSWV3?oc=5", "source_name": "koreabiomed.com", "published_at": "2026-02-13T08:00:00+00:00", "published_display": "13 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "JW Pharmaceutical shares real-world prescribing data for immune thrombocytopenia drug Tavalisse", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE1Hd0RWQlZZWktHMXdXa0diUG9mQ1dPc3JnMUFPVFZKNUItY0c5QVBkWnF3MUpWSmVPMk5vUDRXajFUMVlMR2tRS0hDNk1uUGExSGNPSzlkZ1htVlRna2VFZFR0MmRSSmh4RU9qUDlB0gFyQVVfeXFMTzJLMWNjSHVTWU9qbUdIOUE4dk83QmRJSGRBSjhQZndDTVhQZk5yQUdsZGRJdHlseG5iM3Nubm5NSGJ5LVpZQi0xeWd3aGRmR3Z6ZjQxZVBqUTRYWDhscF8zSTFwRWJGT2FOdGJDOUdRSk9n?oc=5", "source_name": "koreabiomed.com", "published_at": "2026-01-26T08:00:00+00:00", "published_display": "26 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "JW Pharmaceutical Registers U.S. Patent for Hair Loss Treatment JW0061", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxQYjRQbzhDX0wtZml5RkU0SEE3SkpZd2Y0VzdvZXJELXBOakE1cmlmM21GS3djeHFlRGhtVG9BdmlNSU1hN2w3YXNaaV9Wc3NMNGtZYmpST0hqQmJUaVhUSS1FejlwcG04RDNzSGdETVlSbkJYUHpLSl92WU5tellFWVRKcm4tZUpQ?oc=5", "source_name": "\uc870\uc120\uc77c\ubcf4", "published_at": "2026-01-19T08:00:00+00:00", "published_display": "19 Jan 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "JW Pharmaceutical\u2019s Hemlibra earns spot on WHO\u2019s 2025 essential medicines list for hemophilia A", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTFA2QVZQNXdlcjBuWnlTVzJXTjNGd25xbUxyNjZSdGVXUzF6XzlsWDBsWVhkSWRfOVJxR0ZCUk5sRFlOenZBSTZ3TEtBR1hrSHEyTlpZdV9yUE9PdmFxQjUwYjRUUlFzYTJPQXQ0TWJ30gFyQVVfeXFMTlEtckJFd2ZpTkowR1FBdnd0aEZZMDlsV192OTV6VnhXZnpHTDNWV1R3NXRpU2FuU2xtYmdBb0FCT0U5MlQ0OUlhR2ItU2ZxMkxQbFhyZjNsQnVBVGJZdEt3ODUyeWYzVHZZbm0xNmtOZEd3?oc=5", "source_name": "koreabiomed.com", "published_at": "2025-10-20T07:00:00+00:00", "published_display": "20 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LEO Pharma returns rights for atopic dermatitis drug candidate to JW Pharmaceutical due to lack of efficacy", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE5JYWJiVW51bDItQlpKQzhGcFZxZl9ZbDNTcE54eDQ1NTd1UnVkMTlCdVRvdkxjc2FmclhseVdKcWZUMXp2el9ieUNGY19BelU2dko1NzZwRzJ1TnJHYmhRdWMwbXUxYWNkelhlcXhR0gFyQVVfeXFMTjJNNG9rR01rZ2I0MEhxN2tJQnFLZHhmNGljV3Z3QnlUUTdyUEVZSU9NMzJ0emVZLTIyaDF2ZTgxWk5rY19YNExtWXh6a2lyX0c4a0FBbnI1eDVXVkxBZnZCay1iTXhDNm5Xd3Z2WHhTS3VR?oc=5", "source_name": "koreabiomed.com", "published_at": "2023-10-23T07:00:00+00:00", "published_display": "23 Oct 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 54, "total_relevant": 15, "sentiment_summary": {"positive": 0, "negative": 4, "neutral": 11, "score": 46, "total": 15, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 86, "events": [{"event": "general", "label": "Market update", "weight": 6.05, "count": 11}, {"event": "deals", "label": "Deals and strategy", "weight": 1.65, "count": 3}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 4}, "market_context": {"has_market_context": true, "latest_close": 26700.0, "latest_week": "2026-06-19", "one_week_move": -1.3, "four_week_move": -10.9, "twelve_week_move": -14.9, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.345051, "market_dynamics_buy_signal": false, "relative_strength": -49.078884, "fair_value_gap": -3.0, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 49.9601, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-1.3% over one week, -10.9% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 65, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "koreabiomed.com", "count": 6}, {"label": "Chosunbiz", "count": 2}, {"label": "Seoul Economic Daily", "count": 2}, {"label": "Business Wire", "count": 1}, {"label": "Pharmaceutical Technology", "count": 1}, {"label": "PR Newswire", "count": 1}, {"label": "The Korea Herald", "count": 1}, {"label": "\uc870\uc120\uc77c\ubcf4", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 15}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 11}, {"label": "Deals and strategy", "count": 3}, {"label": "Earnings", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "46/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "86/100 classification confidence."}, {"label": "Company focus", "value": "15", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-1.3% over one week, -10.9% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "JW Pharmaceutical leads South Korea AI-robot drive to speed cancer drug discovery - CHOSUNBIZ"}], "updated_at": "2026-06-22T20:45:33.228324+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}